IL-6 signaling | Barrier dysfunction | Angiogenesis | VEGF signaling | Diabetic retinopathy | Dry eye disease | Translational research
Shruti Sharma, MS, PhD
Associate Professor
Center for Biotechnology & Genomic Medicine
James and Jean Culver Vision Discovery Institute
Department of Ophthalmology
Medical College of Georgia at Augusta University
706-721-6522
Office: CA-4139 | Lab: CA-4132A
Jump to: Research Interests Projects Funding & Teaching Media Articles & Publications Graduate Students & Staff
The Shruti Sharma Lab investigates the role of inflammation-induced endothelial dysfunction in diabetic retinopathy (DR).
The lab has identified interleukin-6 (IL-6) trans-signaling as a novel therapeutic target and demonstrated that the IL-6 inhibitor sgp130Fc (Olamkicept) effectively reduces inflammation, oxidative stress, and retinal vascular damage in DR. This has led to an expanded focus on the roles of Müller glial cells, pericytes, and VEGF signaling in retinal diseases including the use of oxygen-induced retinopathy animal models to study Müller cell-mediated IL-6 signaling in ischemic angiogenesis. The Sharma lab is also exploring human tear protein biomarkers and conducting in-vitro studies using osmoprotectants to identify new therapeutic targets for dry eye disease (DED), with the overarching goal of developing therapies that preserve retinal and ocular surface health.
IL-6 is a pleiotropic cytokine that possess both anti- and pro-inflammatory properties. Our lab found that inhibiting pro-inflammatory, IL-6 trans-signaling, attenuates inflammation, and helps prevent the vascular dysfunction in the retina that can lead to vision loss.
Our lab investigates the role of inflammation in DED, to find alternative therapeutic interventions. We center our work on understanding the mechanisms behind tear film instability and increased tear osmolarity, which are the major characteristics of DED.
Nile red staining in hTCEpi cells
Our large collection of human tear samples allow us to identify DED tear biomarkers to further advance our search for potential therapeutic DED targets.
Proteins detected in human tear samples
Funding:
Teaching:
Richard Kontoh-Twumasi
706-721-3404
Graduated Students
Rebekah Robinson
Arthur Miller, MD
Medical Residents & Students
Neel Edupuganti
706-731-3404
Laboratory Staff